A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NF1 / neurofibromin 1

[Related PubMed/MEDLINE]
Total Number of Papers: 77
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NF1  (>> Co-occurring Abbreviation)
Long Form:   neurofibromin 1
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 Genomic Sequencing of Cancer-related Genes in Sinonasal Squamous Cell Carcinoma and Coexisting Inverted Papilloma. CDKN2A, CYP2D6, EGFR, FLT4, MYH9, PDE4DIP, SCC, SNIP, TP53
2021 Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine. AhR, Baf A, CQ, HCQ, MMP-1
2021 MiR-27a-3p/miR-27b-3p Promotes Neurofibromatosis Type 1 via Targeting of NF1. CCK-8, EdU, HSC, miRNAs, MPNSTs, mRNA, RIP, RT-qPCR, TUNEL
2021 Normal Mode Analysis of KRas4B Reveals Partner Specific Dynamics. ANM, GNM, NMA, SOS1
2021 The isolated GTPase-activating-protein-related domain of neurofibromin-1 has a low conformational stability in solution. CD, DSC, GAP, SEC
2020 Analysis of genes within the schizophrenia-linked 22q11.2 deletion identifies interaction of night owl/LZTR1 and NF1 in GABAergic sleep control. DS
2020 Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis. ---
2020 Fibroblast‑derived exosomal microRNA‑369 potentiates migration and invasion of lung squamous cell carcinoma cells via NF1‑mediated MAPK signaling pathway. CAFs, LUSC
2020 From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath Tumor. MPNST, PRC2
10  2020 Is There an Independent Role of TERT and NF1 in High Grade Gliomas? muts, OS, pts, TERT, WT
11  2020 Population structure, genetic diversity, and selective signature of Chaka sheep revealed by whole genome sequencing. CAPN3, GDF3, HDAC9, He, Ho, IGF1, LD, MYOM1, ROH, TGFBR2
12  2020 RAS internal tandem duplication disrupts GTPase-activating protein (GAP) binding to activate oncogenic signaling. ERK, GAP, ITD, MEK, RAF
13  2020 Social Behavioral Deficits with Loss of Neurofibromin Emerge from Peripheral Chemosensory Neuron Dysfunction. ---
14  2020 The novel duplication HRAS c.186_206dup p.(Glu62_Arg68dup): clinical and functional aspects. CS, GAP, PLCE1, RALGDS
15  2020 Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma. GBM, MA-TAMs, MARCO, PI3K-mTOR-AKT
16  2019 A functional genetic screen defines the AKT-induced senescence signaling network. AIS, OIS
17  2019 Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer. APC, AR, ARID1A, cfDNA, ctDNA, CTNNB1, EGFR, mCRPC, OS, PIK3CA
18  2019 Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma. CJM, Hsp90, mTOR, PTEN, TERT
19  2019 Feasibility of using NF1-GRD and AAV for gene replacement therapy in NF1-associated tumors. AAV, GRD, HSCs, MPNSTs
20  2019 Intrinsic Resistance to MEK Inhibition through BET Protein-Mediated Kinome Reprogramming in NF1-Deficient Ovarian Cancer. BET, EOC, MEKi, RTK
21  2019 Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth. CCK-8, ChIP-seq, EdU, HMGA2, IHC, MPNSTs, MSI2, RNA-Seq
22  2019 NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas. NGS
23  2019 NF1-cAMP signaling dissociates cell type-specific contributions of striatal medium spiny neurons to reward valuation and motor control. MSNs
24  2019 [Spindle and giant cell type undifferentiated carcinoma of the distal bile duct: a case report]. CCND3, FGFR4
25  2018 CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma. CAPN1
26  2018 Conditional Inactivation of Nf1 and Pten in Schwann Cells Results in Abnormal Neuromuscular Junction Maturation. Chrna1, Dag1, Dmd, LAMB2, NMJ, PSCs, PTEN, SCs
27  2018 Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells. ---
28  2018 Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1. ---
29  2018 Metabolic Subtyping of Pheochromocytoma and Paraganglioma by 18F-FDG Pharmacokinetics Using Dynamic PET/CT Scanning. SDH, Vb, VHL
30  2018 Molecular characterization and pathogenesis of gastrointestinal stromal tumor. GISTs, PDGFRA, SDH
31  2018 Neurofibromin 1 Impairs Natural Killer T-Cell-Dependent Antitumor Immunity against a T-Cell Lymphoma. NKT, WT
32  2018 NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome. AML, CR, ELN, OS, Thr676
33  2018 Racial Disparities in the Molecular Landscape of Cancer. AA, ATM, CC, CRC, EGFR, HGG, MPL, NSCLC, PD-L1, PIK3CA, PTEN, PTPN11, TOP2A, TP53
34  2018 Recurrent Gastric Gastrointestinal Stromal Tumor in a Patient with Neurofibromatosis. GI, GISTs
35  2017 A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma. AUROC, GBM
36  2017 A Transposon-based Analysis Reveals RASA1 Is Involved in Triple-Negative Breast Cancer. Rasa1
37  2017 Atypical neurofibromatosis type 1 with unilateral limb hypertrophy mimicking overgrowth syndrome. ---
38  2017 Phenformin Enhances the Efficacy of ERK Inhibition in NF1-Mutant Melanoma. ERK
39  2016 Neurofibromatosis type 1 associated with pheochromocytoma and gastrointestinal stromal tumors: A case report and literature review. GIST, PHEO
40  2016 NF1 Is a Direct G Protein Effector Essential for Opioid Signaling to Ras in the Striatum. GPCRs
41  2016 Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations. ---
42  2015 Characterization of NF1 frameshift mutations in pediatric patients with neurofibromatosis type I. ---
43  2015 Cutting Edge: Codeletion of the Ras GTPase-Activating Proteins (RasGAPs) Neurofibromin 1 and p120 RasGAP in T Cells Results in the Development of T Cell Acute Lymphoblastic Leukemia. RasGAPs
44  2015 Genomic landscape of liposarcoma. CPM, LPS
45  2015 Latent tri-lineage potential of adult hippocampal neural stem cells revealed by Nf1 inactivation. NSCs
46  2015 Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors. CNA, FFPE, MED12, NGS
47  2015 Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters. MAX, NET, VHL
48  2015 Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case. GISTs, MAX, PDGFRA, SDH
49  2015 [A novel indel NF1 mutation identified in a patient with neurofibromatosis type 1]. ---
50  2014 Desmoplastic melanoma with sarcomatoid dedifferentiation. DM
51  2014 Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumors. MPNST, RT
52  2013 Association mapping of genetic risk factors for chronic wasting disease in wild deer. CWD
53  2013 Clinical and molecular prognostic predictors of malignant peripheral nerve sheath tumor. AJCC, MPNST
54  2013 MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1. HNSCC, miRNAs
55  2013 Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis. MPNSTs, NRG1
56  2013 NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. hSCs, MPNSTs, PNs, SCs, siRNA
57  2013 NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition. MAPK, MPNST
58  2013 Polycythemia vera and essential thrombocythemia: new developments in biology with therapeutic implications. ASXL1, DNMT3A, EZH2, IDH, IKZF, JAK-STAT, SRSF2, TET2
59  2013 Polymorphism in the neurofibromin gene, Nf1, is associated with antagonistic selection on wing size and development time in Drosophila melanogaster. InDel, LD
60  2013 The Ras GTPase-activating protein neurofibromin 1 promotes the positive selection of thymocytes. RasGAPs
61  2013 The ras-GTPase activity of neurofibromin restrains ERK-dependent FGFR signaling during endochondral bone formation. FGFR, MMP-9, WT
62  2012 Comparative oncogenomics implicates the neurofibromin 1 gene (NF1) as a breast cancer driver. CNAs
63  2012 Nf1 limits epicardial derivative expansion by regulating epithelial to mesenchymal transition and proliferation. cVSMCs, EMT, EPDCs
64  2012 NF1 microduplications: identification of seven nonrelated individuals provides further characterization of the phenotype. DD, ID, NAHR
65  2012 PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors. MPNST, NF-1, PNST, PTEN
66  2012 Sensitivity of glioblastomas to clinically available MEK inhibitors is defined by neurofibromin 1 deficiency. GBM, PI3K
67  2012 The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells. CREB, miR-9
68  2012 The neurofibromin 1 type I isoform predominance characterises female population affected by sporadic breast cancer: preliminary data. ---
69  2012 Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development. JMML, MPNSTs, OPCs
70  2011 Another VCP interactor: NF is enough. VCP
71  2010 NF1 inactivation in adult acute myelogenous leukemia. AML, mTOR
72  2008 Alphavirus production is inhibited in neurofibromin 1-deficient cells through activated RAS signalling. SINV, WT
73  2008 Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations. OSC
74  2006 Comparison of DNA variants in the PRNP and NF1 regions between bovine spongiform encephalopathy and control cattle. BSE
75  2006 Leukemia-associated, constitutively active mutants of SHP2 protein tyrosine phosphatase inhibit NF1 transcriptional activation by the interferon consensus sequence binding protein. ICSBP, SHP2-PTP
76  2004 The interferon consensus sequence-binding protein activates transcription of the gene encoding neurofibromin 1. GM-CSF, ICSBP, M-CSF
77  1996 The differential effects of the Gly-60 to Ala mutation on the interaction of H-Ras p21 with different downstream targets. GAP, ralGDS